Ultimovacs’ Chief Scientific Officer Gustav Gaudernack Receives Norwegian Tech Award’s Honorary Prize as an Outstanding Pioneer Against Cancer
NON-REGULATORY PRESS RELEASE The Honorary Prize is awarded to an individual who has left a…
Month: June 2023
Workato’s Software License Optimization Accelerator Named “IT Asset Management Solution of the Year” by RemoteTech Breakthrough Awards
Annual awards recognize the world’s best technology powering remote work MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Workato, the…
Better Choice Announces Strategic Investment from Alphia of $5 Million, Establishes Multi-Year Manufacturing Partnership
The investment will restructure company debt, supporting sustainable, long-term business growth NEW YORK, June 22,…
Verizon upgrades network for Buffalo customers
Recent upgrades result in testing outcomes that show customers have the best experience on the…
Plurilock Announces Closing of First Tranche of Non-Brokered Private Placement
Vancouver, British Columbia–(Newsfile Corp. – June 22, 2023) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB:…
FUJIFILM Irvine Scientific Offers Expanded Capabilities of Presagen’s Life Whisperer Platform to Aid with Clinical Decision-Making in IVF
Genetics AI-based software module added to provide objective scoring of embryo genetic integrity and likelihood…
Gearlinx™ Revolutionizes Network Resilience with the Launch of NR4400 Network Resilience Platform, Duckfone™ Cellular Gateway, and ZERO Cloud Management Portal
FRISCO, Texas–(BUSINESS WIRE)–Gearlinx™, a leading cloud software as a service innovator and pioneer of network…
Uniphore Appoints Tushar Shah as Chief Product Officer
PALO ALTO, Calif.–(BUSINESS WIRE)–#AI—Uniphore, one of the largest global AI-native conversational AI providers for the…
MosaicML Releases Open-Source MPT-30B LLMs, Trained on H100s to Power Generative AI Applications
SAN FRANCISCO–(BUSINESS WIRE)–MosaicML announces the availability of MPT-30B Base, Instruct, and Chat, the most advanced…
How To Build An Eco-Friendly Data Center – And A More Competitive Business
By Ian Clatworthy, Director of Data Platform Product Marketing, Hitachi Vantara Sustainability is a mega…
Optimizing Outcomes Through Micro Molding – An Expert Perspective
For companies that are exploring the possibilities that exist for miniaturization of plastic parts and…
Accumulus Synergy Appoints Jacques Mascaro as Chair of the Board
BURLINGAME, Calif., June 22, 2023 (GLOBE NEWSWIRE) — Accumulus Synergy (“Accumulus”), a nonprofit trade association…
SELLAS Announces First Patient Dosed in Phase 2a Clinical Trial of GFH009 in Acute Myeloid Leukemia
NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Health Extract’s Whitney Johns™ Natural Health & Fitness Products to be Featured by Amazon Across Multiple Channels for Amazon Prime Day
WhitneyJohns.com Offering Exclusive Amazon ‘Buy with Prime’ Discounts Today in Advance of Prime Day Whitney…
PaxMedica Comments on Common Stock Volatility
Engages ShareIntel to Track Market Activity TARRYTOWN, NY, June 22, 2023 (GLOBE NEWSWIRE) — via…
Kymera Therapeutics Receives FDA Orphan Drug Designation for KT-253, a Novel, Highly Potent and Selective MDM2 Degrader for the Treatment of Acute Myeloid Leukemia
WATERTOWN, Mass., June 22, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
Regeneration and Reinnervation of Spinal Cord in Rats Treated with NurExone’s Intranasal ExoPTEN
Figs. 1A-B Diffusion Tensor Imaging and Measurements TORONTO and TEL AVIV, Israel, June 22, 2023…
Avadel Pharmaceuticals to Host Commercial Day on June 29 for LUMRYZ™ (sodium oxybate) extended release for oral solution, CIII
DUBLIN, Ireland, June 22, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada
VANCOUVER, British Columbia, June 22, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Cidara Therapeutics Receives U.S. FDA Fast Track Designation for CD388, a Novel Drug-Fc Conjugate Targeting Influenza A and B
SAN DIEGO, June 22, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology…